Let's Talk About This

Altering the human germline through genome editing needs further ethical discussion by the scientific community, the White House says.

"The Administration believes that altering the human germline for clinical purposes is a line that should not be crossed at this time," writes John Holdren, the director of the White House Office of Science and Technology Policy, in a blog post.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.